Chemistry and Pharmacology of Anticancer Drugs 2e By David E. Thurston, Ilona Pysz
Get link
Facebook
X
Pinterest
Email
Other Apps
Chemistry and Pharmacology of Anticancer Drugs 2e By David E. Thurston, Ilona Pysz
What this book offers
「Comprehensive scope」: All major families of anticancer agents are covered. That includes classical cytotoxic drugs, antimetabolites, antitubulin agents, nucleic acid‐targeted agents, small-molecule targeted therapies, antibody-based treatments, endocrine therapies, immunomodulatory methods, alternative tumor-targeting strategies, precision medicine approaches, and chemopreventive agents.
「Depth of chemical and pharmacological detail」: For every agent or class, the authors provide molecular structures, mechanisms of action, structure-activity relationships, pharmacokinetics/dynamics, side effects, dosing, and formulation matters. This is not merely listing molecules—it connects chemical structure to function, toxicity, and clinical utility.
「Historical and developmental context」: The book traces how anticancer therapies have evolved (from early cytotoxics through to modern precision medicine), so the reader can appreciate why certain strategies succeeded or failed, and what the emerging frontiers are.
「Modern themes」: It contains up-to-date treatments of precision medicine, biomarkers, pharmacogenetics/genomics, novel tumor-targeting strategies, and chemoprevention.
「Educational value and didactic structure」: The chapters are logically ordered (starting from Introduction to Cancer, the evolution of therapies, then classes of drugs, then advanced and alternative strategies). Each chapter includes illustrations, tables, molecular structures. Useful for advanced undergraduates, postgraduates, and researchers.
Key new or especially valuable chapters
「“The Evolution of Anticancer Therapies”」: Puts into view the shifts in paradigm — not only incremental improvements, but how thinking about cancer treatment has changed (e.g. targeted vs non-specific cytotoxics).
「“Antibody-Based Therapies”」: Given the rise of immune-based, biologic, antibody-drug conjugates, this chapter is especially important. It covers both chemical aspects (e.g. payload design, conjugation) and pharmacological/clinical behaviour.
「“Precision Medicine Approach in Oncology”」: Covers biomarkers, pharmacogenomics, patient stratification, etc. For researchers working in personalized therapies, this is central.
「“Chemopreventive Agents”」: Sometimes neglected; this shows that prevention is also a part of the anticancer drug universe—not just treatment.
Some metrics
「Pages」: ~592 pages.
「Illustrations」: According to publisher data, there are hundreds of black-and-white illustrations (molecular structures, mechanisms, etc.) and many tables to help synthesise information.
「ISBN」: 978-1-4398-5326-9 (hardcover) for 2nd edition published in 2021.
Why this is important
Cancer remains one of the top causes of mortality and morbidity globally. Despite substantial advances, many existing therapies still have unacceptable toxicity, limited specificity, resistance issues, and variable responses among patients. This book helps fill the gap between pure chemistry, pure biology, and clinical practice. It provides a map of how chemical innovations map onto therapeutic progress, how adverse effects limit usage, and how newer paradigms (precision medicine, antibody-based therapies, etc.) are being integrated. 🧬
Also, for anyone involved in designing new anticancer agents (academic or industrial), understanding the current landscape is essential: which molecular targets are saturated, which structural motifs are promising or problematic, what delivery/formulation issues are still open, what resistance mechanisms persist. This book helps you see “where to push next.”
Suggestions for readers
Don’t try to read it cover-to-cover in one go. Some chapters (e.g. Antimetabolites, Nucleic Acids as Therapeutic Targets) are dense with chemistry; having a strong foundation in organic chemistry and pharmacokinetics is helpful.
Keep an eye on the newer content in the 2nd edition: the precision medicine and immunomodulatory chapters are likely to age more quickly—so supplement with current literature in those areas.
Conclusion
Chemistry and Pharmacology of Anticancer Drugs (2nd ed.) by Thurston & Pysz is an essential addition to the library of anyone working seriously in anticancer research or therapeutics. It strikes a rare balance: rigorous chemical detail, mechanistic insight, clinical relevance, and exposure to emergent themes in oncology. For those of us who want not just to treat cancer, but to understand how every bond, every functional group, every side-chain contributes to success or failure, this book is extremely valuable. Highly recommended. ✅
Astrochemistry The Physical Chemistry of the Universe 2e By Andrew Shaw 🌌 A Journey into the Molecular Cosmos: Introducing Astrochemistry: The Physical Chemistry of the Universe, 2e 🌠 It is my pleasure (and minor professional obligation) to introduce a work of ambition and rigor: 「 Astrochemistry: The Physical Chemistry of the Universe, 2nd Edition 」 by Andrew M. Shaw . This book stakes a claim at the confluence of physical chemistry , astronomy , and astrobiology . It is not mere popular science; it is designed for those who are comfortable navigating thermodynamics , kinetic networks , quantum transitions , and cosmological backdrops .
Cambridge International ASA Level Chemistry Study and Revision Guide 3e by David Bevan It is with considerable enthusiasm (and a measure of scholarly obligation) that I introduce 「Cambridge International AS/A Level Chemistry Study and Revision Guide, 3rd Edition」 , authored by 「 David Bevan 」 and published by Hodder Education . This is not merely another “test prep” volume but rather a carefully structured companion that bridges rigorous content mastery and examination strategy. 🧪📘
Comments
Post a Comment